Transistion from manual to femto keratoplasty

Article

A commitment to predictability and safety

The introduction of femtosecond laser technology in the ophthalmologic practice has given rise to significant advances in a great variety of corneal surgical procedures, especially in terms of predictability and safety. This technology, based on the use of a solid state laser (Nd:Glass) beam of a wavelength of 1040–1060 nm, is able to induce a photodisruption of the corneal tissue at a specific plane without thermal or shockwave damage to the surrounding tissue, and with a extremely high level of precision. Specifically, femtosecond lasers form a series of microbubbles (3–12 µm) of carbon dioxide and water vapour due to the photodisruption induced at the programmed depth. These microbubbles interconnect generating a dissection plane. This capability of femtosecond laser technology of precisely programming and generating different types of corneal tissue dissections makes it a valuable tool for keratoplasty.

A valuable tool

Another significant advantage of femto keratoplasty is the possibility of customizing the corneal trephination according to an established pattern. As presented at Femto Keratoplasty Forum 2012 by Dr Thomas Neuhann, it is highly recommended to use dissections with an internal diameter smaller than the external and slanted inwards to promote good self healing.7 This can easily be achieved with the zigzag, tongue in groove ('barrel'), and 'square-zag' shapes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.